98 related articles for article (PubMed ID: 4377809)
1. [Discussion of a case of dyschromia].
Nicolay M; Piot V
Arch Belg Dermatol; 1974; 30(2):99-101. PubMed ID: 4377809
[No Abstract] [Full Text] [Related]
2. [Hypersensitivity to tetracosactide].
Ligumski M; Kletter-Chemo D; Penchas S
Harefuah; 1977 Feb; 92(4):169-70. PubMed ID: 191336
[No Abstract] [Full Text] [Related]
3. Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema.
Munro DD
Br J Dermatol; 1976 Mar; 94 suppl 12():135-8. PubMed ID: 178340
[TBL] [Abstract][Full Text] [Related]
4. [Use of Cortrosyn Depot in dermatology].
Aussems J
Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
[No Abstract] [Full Text] [Related]
5. [Tetracosactide in the treatment of rheumatoid arthritis and gout].
Usobiaga JL
Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406
[No Abstract] [Full Text] [Related]
6. [Synacthene-Retard in mental confusion of aged patients].
Porte M; Juttner G; Michelangeli J; Krebs BP; Lavagna J; Capdeville C; Darcourt G
Ann Med Psychol (Paris); 1979; 137(5):481-90. PubMed ID: 228577
[No Abstract] [Full Text] [Related]
7. [Synacthen retard].
Ménégol B; Brard M
Soins; 1985 Apr; (451):I-II. PubMed ID: 3008345
[No Abstract] [Full Text] [Related]
8. [Value of depot synacthen therapy in dermatoses. A report of over 6-years' experiences].
Harnack K; Flegel P
Dermatol Monatsschr; 1984; 170(4):237-43. PubMed ID: 6329833
[No Abstract] [Full Text] [Related]
9. [ACTH therapy of dermatoses].
Schuppli R
Hautarzt; 1977 Jan; 28(1):1-4. PubMed ID: 190189
[No Abstract] [Full Text] [Related]
10. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)].
Bordier C; Flechet ML; Thomine E; Lauret P
Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213
[No Abstract] [Full Text] [Related]
11. [Adverse effects of synthetic ACTH (tetracosactide-Zn)--asthmatic attack and shock-report of 2 cases].
Kawai M; Maekawa N
Nihon Kyobu Shikkan Gakkai Zasshi; 1975 Nov; 13(11):663-70. PubMed ID: 176495
[No Abstract] [Full Text] [Related]
12. [Tetracosactide in the acute phase of cerebrovascular accidents].
Cornaert P
Lille Med; 1980; 25(7):384-6. PubMed ID: 6253756
[No Abstract] [Full Text] [Related]
13. [Metabolic disorders induced by a combination of sodium gamma-hydroxybutyrate and tetracosactide in head-injury patients].
Béal JL; Freysz M; Honnart D; Wilkening M
Therapie; 1983; 38(5):569-71. PubMed ID: 6322376
[No Abstract] [Full Text] [Related]
14. [Synacthen depot-induced liver damage in the therapy of secondary generalized epilepsies in childhood].
John K; Gaida P; Kauf E
Padiatr Grenzgeb; 1985; 24(5):391-9. PubMed ID: 2999679
[No Abstract] [Full Text] [Related]
15. [Fatal complication of intravenous administration of synthetic adrenocorticotrophin].
Müller M; Fehm HL; Homoki J; Teller WM
Dtsch Med Wochenschr; 1982 Sep; 107(36):1353-6. PubMed ID: 6288339
[TBL] [Abstract][Full Text] [Related]
16. West's syndrome and its treatment.
Sorel L
Clin Electroencephalogr; 1985 Jul; 16(3):122-7. PubMed ID: 2994911
[No Abstract] [Full Text] [Related]
17. [Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide].
Cret L; David M; Macabéo V; Frédérich A; Jeune M
Pediatrie; 1976; 31(1):33-48. PubMed ID: 184427
[No Abstract] [Full Text] [Related]
18. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
Kropp R
Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022
[TBL] [Abstract][Full Text] [Related]
19. Steroidstoss therapy in the treatment of herpes zoster.
Sutton G
Br J Clin Pract; 1984 Jan; 38(1):21-4. PubMed ID: 6322830
[No Abstract] [Full Text] [Related]
20. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.
Glass D; Roffe L; Maini RN; Wraith DG; Nuki G
Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
